Notice of Informational Webinar for RFA-AI-23-077, Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scales (U54 Clinical Trial Not Allowed).
Notice NOT-AI-24-042 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 18, 2024 Category: Research Source Type: funding
Notice of Change to Application Due Date for PAR-24-062, "Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)"
Notice NOT-DA-24-026 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 17, 2024 Category: Research Source Type: funding
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-197 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to identify new druggable targets for pain within the understudied druggable proteome. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s) listed in this NOFO. This NOFO is intended to jumpstart research on understudied proteins within the context of pain and pain management and provide applicants with sufficient funding to perform basic biochemical and/or biological work to further the charac...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 17, 2024 Category: Research Source Type: funding
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Funding Opportunity PAR-24-174 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 17, 2024 Category: Research Source Type: funding
Notice of Extension of the Expiration Date of PAR-23-114, "Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)"
Notice NOT-EB-24-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 17, 2024 Category: Research Source Type: funding
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
Funding Opportunity RFA-MH-25-130 from the NIH Guide for Grants and Contracts. NIMH seeks applications for pilot research to adapt, optimize, and test empirically supported behavioral interventions that address common sleep problems in adolescents and young adults with or at risk for a mental health disorder. Pilot trials should be designed to evaluate the feasibility, tolerability, acceptability, safety, and potential effectiveness of the approach in real world settings, and to conduct a preliminary test of the interventions impact on target mechanisms and sleep and mental health outcomes, and to obtain preliminary dat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 17, 2024 Category: Research Source Type: funding
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance Use and Mental Health Disorders (R01 Clinical Trial Required)
Funding Opportunity RFA-DA-25-035 from the NIH Guide for Grants and Contracts. This NOFO seeks applications from the SUD and MHD research communities that coordinate efforts to characterize the effects of neuromodulation on brain circuits and behaviors relevant to both SUD and MHD. To accomplish this goal, studies would specify inclusion/exclusion criteria to capture variance in both SUD and MHD symptoms. Further, studies would include measures of engagement of circuit-level targets in response to neuromodulation and dimensional measures of cognition and behavior relevant to both SUD and MHD. This research approach uses...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 15, 2024 Category: Research Source Type: funding
NEI Notice of Participation in PA-24-185, "Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)"
Notice NOT-EY-24-003 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 15, 2024 Category: Research Source Type: funding
Notice of Expiration of PAR-22-261 "Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
Notice NOT-HD-24-017 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 15, 2024 Category: Research Source Type: funding
Notice of Extension of the Expiration Date of PAR-22-000, "Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)"
Notice NOT-EB-24-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 15, 2024 Category: Research Source Type: funding
Notice of Renewal / Resubmission / Revision Application Due Date Correction to PAR-24-172 "NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)"
Notice NOT-HL-24-011 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 15, 2024 Category: Research Source Type: funding
Notice of Change to Foreign Component Eligibility in RFA-OD-24-014 "Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)"
Notice NOT-AT-24-040 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 12, 2024 Category: Research Source Type: funding
Notice of Change to NHGRI-specific language in RFA-HG-23-017, Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
Notice NOT-HG-24-031 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 12, 2024 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
Notice NOT-HD-24-018 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 12, 2024 Category: Research Source Type: funding
Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)
Funding Opportunity PAR-24-203 from the NIH Guide for Grants and Contracts. This NOFO will solicit R01 applications that propose studies in animal, cell culture, and/or human tissue models to elucidate the mechanisms by which COVID-19 interacts with and/or modulates AD/ADRD-relevant phenotypes. Either the model itself or the experimental readouts will be required to incorporate AD/ADRD risk factors, pathologies, or relevant comorbidities. To this end, proposals can focus on one or more of the following: - Mechanistic studies that address how COVID-19 impacts CNS pathology and cognitive outcomes when AD/ADRD pathology is...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 12, 2024 Category: Research Source Type: funding
